Last reviewed · How we verify

Intragastric quinine hydrochloride — Competitive Intelligence Brief

Intragastric quinine hydrochloride (Intragastric quinine hydrochloride) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Cinchona alkaloid. Area: Neurology / Musculoskeletal.

marketed Cinchona alkaloid Neurology / Musculoskeletal Small molecule Live · refreshed every 30 min

Target snapshot

Intragastric quinine hydrochloride (Intragastric quinine hydrochloride) — Universitaire Ziekenhuizen KU Leuven. Quinine hydrochloride acts as a cinchona alkaloid that reduces muscle excitability and contractility, primarily used to treat nocturnal leg cramps through local gastric delivery.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Intragastric quinine hydrochloride TARGET Intragastric quinine hydrochloride Universitaire Ziekenhuizen KU Leuven marketed Cinchona alkaloid

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Cinchona alkaloid class)

  1. Universitaire Ziekenhuizen KU Leuven · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Intragastric quinine hydrochloride — Competitive Intelligence Brief. https://druglandscape.com/ci/intragastric-quinine-hydrochloride. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: